News and Comments

Biogen: A Fruitful Collaboration in Gene Therapy. A Small Gene Therapy Firm That You Should Know

  Tuesday, May 17, 2016

COLLABORATIONS  More...

Biogen Idec Pays Elan $3.25 billion For Tysabri. Do We Leave, Or Stay?

  Wednesday, February 06, 2013

 More...

Elan's Choices

  Saturday, April 16, 2011

Biogen Idec (BIIB) announced positive results of a process aimed at Identifying high-risk patients for a life-threatening side effect of prolonged use of the multiple sclerosis drug Tysabri. This test is a necessity because it detects an antibody that points to the presence of the Polyomavirus JC (JC virus), which causes the life-threatening progressive multifocal leukoencephalopathy (PML). This side effect in one per thousand patients has deprived Elan from billions of dollars in expected sales of Tysabri.  More...


Recent Postings


Archive


Tags

Bellicum (BLCM) Roche (RHHBY) INNOVIVA (INVA) GlaxoSmithKline (GSK) Herceptin Biogen Idec (BIIB) ImmunoGen (IMGN) Merck (MRK) CEMPRA (CEMP) Human Genome Sciences (HGSI) Illumina (ILMN) Inovio (INO) SUNESIS PHARMACEUTICALS (SNSS) Dynavax (DVAX) VANDA (VNDA) Spike Therapeutics (ONCE) Gilead (GILD) NEUROCRINE (NBIX) SERES THERAPEUTICS (MCRB) Aimmune Therapeutics (AIMT) JUNO (JUNO) Endometrial Cancer Sarepta (SRPT) Intercept (ICPT) ARCA (ABIO) Zerenex KERYX (KERX) GUARDIAN HEALTH RenenxBio (RGNX) LEXICON (LXRX) Multiple Myeloma Anacor (ANAC) Revlimid (lenolidamide) Sanofi-Aventis (SAN) Jazz Pharmaceuticals (JAZZ) Valeant Pharmaceuticals International (VRX) Sangamo (SGMO) Human Longevity (HLI) NOVOCURE (NVCR) Agenus (AGEN Sanofi (SNY) Vertex (VRTX) Seattle Genetics (SGEN) Ionis (IONS) Telaprevir Benlysta (belimumab) REGULUS (RGLS) Sequenom (SQNM) Ocular Therapeutix (OCUL) TOKAI (TKAOI) Xoma (XOMA) AERIE PHARMACEUTICALS Adaptimmune (ADAP) Prolor Biotech (PBTH) ACADIA (ACAD) AGOS (ARGS) Micromet (MITI) Dendreon (DNDN) Bristol-Myers Squibb (BMY) AstraZeneca (AZN) Exelixis (EXEL) Onyx (ONXX) ABBVIE (ABBV) OncoCyte (OCX) Intrexon (XON) Amgen (AMGN) ZALTRAP™ ARGOS (ARGS) Galena (GALE) Abbott Laboratories (ABT) BIOMARIN (BMRN) IDERA (IDRA) Cytokinetics (CYTK) Incyte (INCY) Rapamune Mirati Therapeutics (MRTX) Regeneron (REGN) Prosensa (RNA) ADVENTRIX (ANX) PTC Therapeutics (PTCT) Editas (EDIT) CompuGen (CGEN) Global Cell Therapeutics (GBT) Anadys (ANDS) MODERNA Theravance Bio Pharma (TBPH) CRISPR Therapeutics (CRSP) NEKTAR (NKTR)) OSI (OSIP) Biocryst (BCRX) Intermune (ITMN) NANTKWEST (NK) Ariad (ARIA) ISIS (ISIS) JOUNCE THERAPEUTICS (JNCE) Array Pharmaceuticals (ARRY) Auspex (ASPX) C4 Therapeutics KITE (KITE) Ridaforolimus Velcade (bortezomib) PORTOLA (PTLA) SYNTA (SNTA) Elan (ELN) Alnylam (ALNY) Ziofpharm (ZIOP) Theravance (THRX) HALOZYME (HALO) galapagos (GLPG) Genentech Advaxis (ADXS) Trastuzumab-DM1 Roche (ROCHE) Tysabri Idenix (IDIX) Agenus (AGEN) Sanofi (SNA) Vitae Pharmaceuticals (VTAE) Pluristem (PSTI) Alder Biopharmaceuticals (ALDR)